Zobrazeno 1 - 10
of 34
pro vyhledávání: ''
Publikováno v:
Journal of Cancer Research & Clinical Oncology; Dec2022, Vol. 148 Issue 12, p3385-3398, 14p
Publikováno v:
Apoptosis; Aug2019, Vol. 24 Issue 7/8, p612-622, 11p
Autor:
Lu, Yiling, Lin, Yue-Zhen, LaPushin, Ruth, Cuevas, Bruce, Fang, Xianjun, Yu, Shuang Xing, Davies, Michael A, Khan, Humera, Furui, Tatsuro, Mao, Muling, Zinner, Ralph, Hung, Mien-Chi, Steck, Peter, Siminovitch, Kathy, Mills, Gordon B
Publikováno v:
Oncogene. 11/25/99, Vol. 18 Issue 50, p7034. 12p.
Publikováno v:
Acta Pharmacologica Sinica; Dec2009, Vol. 30 Issue 12, p1648-1658, 11p, 1 Chart, 5 Graphs
Autor:
Xiao-Yu Shi, He Lu, Wen-Lin Li, Hong-Lin Tang, Jian-Jun Xiong, Ji-Qing Zhang, Opolon, Paule, Legrand, Chantal, Perricaudet, Michel, Hong Li
Publikováno v:
Journal of Cancer Research & Clinical Oncology; Sep2006, Vol. 132 Issue 9, p561-571, 11p, 12 Graphs
Publikováno v:
Apoptosis; May2005, Vol. 10 Issue 3, p667-678, 12p
Autor:
Toillon, Robert-Alain, Chopin, Valérie, Jouy, Nathalie, Fauquette, William, Boilly, Bénoni, Bourhis, Xuefen
Publikováno v:
Breast Cancer Research & Treatment; Feb2002, Vol. 71 Issue 3, p269-280, 12p
Autor:
Feng Jin, Fan Yao, Yanan Sun, Ayao Guo, Chong Liu, Quanxiu Jin, Chuifeng Fan, Xiaoyun Mao, Bo Li, Shu Guan
Publikováno v:
Tumour Biology
CXCR4 and its ligand CXCL12 can promote the proliferation, survival, and invasion of cancer cells. They have been shown to play an important role in regulating metastasis of breast cancer to specific organs. High CXCR4 expression was also correlated
Publikováno v:
European Journal of Nutrition
Purpose Tamoxifen has been used for the treatment of estrogen receptor (ER)-positive breast cancers and in women who are at an increased risk of breast cancer. Acquired resistance to this drug and its toxicity still pose a clinically significant prob
Autor:
Zhu Liu, Jie Ran, Jun Zhou, Min Liu, Bing Yan, Youguang Luo, Dengwen Li, Xin Dong, Jie Chen, Ruming Liu
Publikováno v:
Protein & Cell
Paclitaxel is a microtubule-targeting agent widely used for the treatment of many solid tumors. However, patients show variable sensitivity to this drug, and effective diagnostic tests predicting drug sensitivity remain to be investigated. Herein, we